2010
DOI: 10.4161/mabs.12187
|View full text |Cite
|
Sign up to set email alerts
|

Mining human antibody repertoires

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
44
0
1

Year Published

2012
2012
2019
2019

Publication Types

Select...
6
3
1

Relationship

1
9

Authors

Journals

citations
Cited by 52 publications
(45 citation statements)
references
References 178 publications
(195 reference statements)
0
44
0
1
Order By: Relevance
“…These include, for instance, phage display, retroviral display, bacterial display, yeast display and various mammalian cell display technologies, in combination with solid surface binding (panning) or other enrichment techniques. 2,3 While phage, 4-6 prokaryotic 7,8 and ribosome/mRNA display 9,10 systems have been established and are widely adopted in the biotechnology industry and in academia for the identification of antibody fragments, they suffer from a variety of limitations, including the inability to express full-length antibodies, the absence of natural post-translational modifications, the lack of proper folding by vertebrate chaperones, and an artificially enforced heavy and light chain combination. Therefore, the "reformatting" of antibody fragments into full-length antibodies followed by manufacturing in mammalian cells frequently results in molecules with unfavorable biophysical properties (e.g., low stability, tendency to aggregate, diminished affinity).…”
Section: Introductionmentioning
confidence: 99%
“…These include, for instance, phage display, retroviral display, bacterial display, yeast display and various mammalian cell display technologies, in combination with solid surface binding (panning) or other enrichment techniques. 2,3 While phage, 4-6 prokaryotic 7,8 and ribosome/mRNA display 9,10 systems have been established and are widely adopted in the biotechnology industry and in academia for the identification of antibody fragments, they suffer from a variety of limitations, including the inability to express full-length antibodies, the absence of natural post-translational modifications, the lack of proper folding by vertebrate chaperones, and an artificially enforced heavy and light chain combination. Therefore, the "reformatting" of antibody fragments into full-length antibodies followed by manufacturing in mammalian cells frequently results in molecules with unfavorable biophysical properties (e.g., low stability, tendency to aggregate, diminished affinity).…”
Section: Introductionmentioning
confidence: 99%
“…9 An appreciation of the complexity and diversity of antibody responses in the human population and the resulting rarity of broadly protective memory B cell clones led to the development PAPer TyPe rePorT of a number of human antibody cloning technologies. 10,11 Herein, we employed a multiplexed screening process to enable an in-depth characterization of the specificity of naturally occurring antibodies secreted from single memory B cells. Deeming multiplexing a critical component to discovering antiviral antibodies with cross-clade activity, we counteracted the associated rapid drop in hit frequency with high throughput and miniaturized assay technologies.…”
Section: Introductionmentioning
confidence: 99%
“…The kappa light chain locus is found in chromosome 2 with the V K , J K and C K gene segments. The lambda LC locus with the V λ , J λ , and C λ gene segments are found on chromosome 22 [37].…”
Section: Generation Of Human Antibody Repertoiresmentioning
confidence: 99%